Our mission is to provide a superior next-generation disinfectant for commercial and industrial use that is non-toxic and sustainable. The patent-pending technology behind Envirocleanse’s anolyte water was brought to the forefront by Dr. Phil Bellan as a means to fight infection in wounds. In late 2015, Charter Brokerage, a BERKSHIRE HATHAWAY unit, bought Envirocleanse to increase Envirocleanse’s size and scope. Since its purchase, the company has begun to expand into the oil-and-gas, medical, food and food distribution, and the ballast-water-treatment industries. The flagship of Envirocleanse is the FDA-approved and EPA-registered disinfectant known as Envirocleanse-A (the A stands for “Anolyte”). The Anolyte solution is hypochlorous acid (HOCL), a nontoxic, non-corrosive biodegradable disinfectant. To find out more, please contact one of our listed team members or visit the website below.